Jianchu Wang

Dr. Jianchu Wang


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2018 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
JWJianchu Wang
Jianchu Wang
JPJian Pu
Jian Pu
YZYing Zhang
Ying Zhang
TYTianwei Yao
Tianwei Yao
ZLZongjiang Luo
Zongjiang Luo
YDYi bin Deng
Yi bin Deng

23 January 2021 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
ZLZongjiang Luo
Zongjiang Luo
LLLibai Lu
Libai Lu
QTQianli Tang
Qianli Tang
WWWang Wei
Wang Wei
PCPengyu Chen
Pengyu Chen
JWJianchu Wang
Jianchu Wang
Hepatocellular carcinoma (HCC) is one of the most common cancers with high prevalence and mortality, and it has brought huge economic and health burden for the world. It is urgent to found novel targets for HCC diagnosis and clinical intervention. Circular RNA (circRNA) has been reported to participate in many cancer progressions including HCC, suggesting that circRNA might paly essential role in HCC initiation and progression. Our study aims to found that potential circRNA participates in HCC development and its underlying molecular mechanisms. We obtained three pairs of HCC tissues and its adjacent normal tissues data from GEO DataSets. MTT, cell colony, EdU, wound‐healing, transwell invasion and mouse xenograft model assays were used to demonstrate the biological functions of circCAMSAP1 in HCC progression. Furthermore, we conducted bioinformatics analysis, AGO2‐RIP, RNA pull‐down and luciferase reporter assays to assess the association of circCAMSAP1‐miR‐1294‐GRAMD1A axis in HCC cells. The expression of circCAMSAP1 was up‐regulated in HCC tissues compared with its adjacent normal tissues. Up‐regulation of circCAMSAP1 promoted HCC biological functions both in vitro and in vivo. The promotive effects of circCAMSAP1 on HCC progression function through miR‐1294/GRAMD1A pathway. CircCAMSAP1 was up‐regulated in HCC tissues, and circCAMSAP1 up‐regulated GRAMD1A expression to promote HCC proliferation, migration and invasion through miR‐1294. CircCAMSAP1 might be a potential prognosis and therapeutic target for HCC.

11 November 2018 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
JWJianchu Wang
Jianchu Wang
JPJian Pu
Jian Pu
TYTianwei Yao
Tianwei Yao
XLXiaojie Lu
Xiaojie Lu
YDYi bin Deng
Yi bin Deng

14 October 2018 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
JWJianchu Wang
Jianchu Wang
ZLZongjiang Luo
Zongjiang Luo
TYTianwei Yao
Tianwei Yao
WLWenchuan Li
Wenchuan Li
JPJian Pu
Jian Pu

26 December 2020 in Aging
Verified
Journal Article
Open access
CZChenyi Zhuo
Chenyi Zhuo
TYTingzhuang Yi
Tingzhuang Yi
JPJian Pu
Jian Pu
XCXiaoning Cen
Xiaoning Cen
YZYang Zhou
Yang Zhou
QTQian-Li Tang
Qian-Li Tang
Exosomes are small vesicles with a diameter of 30-150 nm secreted by cells, which can be used as signal carriers to transfer nucleic acids, proteins, lipids and other functional substances to the recipient cells and play a role in cell communication. Hepatocellular carcinoma is the fourth most common cause of cancer-related death worldwide. Studies have shown that long non-coding RNAs (lncRNAs) are involved in the development and progression of many types of tumors. Our present study found that linc-FAM138B was reduced in HCC tissues and cell lines, low expression of linc-FAM138B indicated a poor prognosis in HCC patients. Interestingly, linc-FAM138B could be packaged into cancer cells. And exo-FAM138B inhibited the proliferation, migration and invasion of HCC cells. Furthermore, linc-FAM138B sponged miR-765 levels. And exo-si-FAM138B promoted HCC progression, while deletion of miR-765 reversed the role of exo-si-FAM138B. In vivo tumorigenesis experiments showed that exo-FAM138B suppressed HCC growth via modulating miR-765. In conclusion, exo-linc-FAM138B secreted by cancer cells inhibited HCC development via targeting miR-765, which provided a new idea and perspective for in-depth understanding of the complex signal regulation in HCC process.

22 January 2021 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
FYFuguo Yan
Fuguo Yan
BFBin Fan
Bin Fan
JWJianchu Wang
Jianchu Wang
WWWang Wei
Wang Wei
QTQianli Tang
Qianli Tang
SYShan-Shan Yang
Shan-Shan Yang
Increasing circRNAs have attracted a lot of attention because of their significant biological effects in many diseases. It has been reported that circ_0008305 can modulate lung cancer progression. However, the association between circ_0008305 and hepatocellular carcinoma (HCC) needs to be well explored. In this current research, we studied the molecular function and potential mechanism of circ_0008305 in HCC progression. First, it was demonstrated that circ_0008305 was greatly increased in HCC tissues and cells. Moreover, we observed silencing circ_0008305 markedly repressed HCC cells in vitro growth and reduced tumor growth in vivo. Additionally, it was identified that circ_0008305 can act as a sponge of miR‐660 while miR‐660 targeted Bcl‐2‐associated athanogene 5 (BAG5). BAG5 belongs to a member of BAG family and it is involved in multiple diseases. We reported that circ_0008305 contributed to the inhibition of miR‐660, which resulted in an upregulated expression of BAG5 in HCC. Subsequently, rescue assays were conducted and it was indicated that loss of BAG5 reversed the effects of miR‐660 inhibitors on HCC partially. To sum up, it was illustrated by our study that circ_0008305‐mediated miR‐660‐5p/BAG5 axis triggered HCC progression, which could provide a novel insight on the underlying mechanism of HCC progression.